GS-621763

N/A

Report date: 2022/12/07 18:09:12
NME

Base Information

Drug NameGS-621763
Drug Alias NameGS-621763
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionRNA-directed RNA polymerase inhibitorsViral proteins inhibitors
TargetsRNA-directed RNA polymeraseViral proteins
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGeorgia State UniversityGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences IncGeorgia State University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A